Cargando…

Evaluation of Models of Parkinson's Disease

Parkinson's disease is one of the most common neurodegenerative diseases. Animal models have contributed a large part to our understanding and therapeutics developed for treatment of PD. There are several more exhaustive reviews of literature that provide the initiated insights into the specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jagmag, Shail A., Tripathi, Naveen, Shukla, Sunil D., Maiti, Sankar, Khurana, Sukant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718050/ https://www.ncbi.nlm.nih.gov/pubmed/26834536 http://dx.doi.org/10.3389/fnins.2015.00503

Ejemplares similares

Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice
por: Bhatnagar, Maheep, et al.
Publicado: (2017)

Critical Evaluation of Ayurvedic Plants for Stimulating Intrinsic Antioxidant Response
por: Shukla, Sunil Dutt, et al.
Publicado: (2012)

Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Commentary: Evaluation of Models of Parkinson's Disease
por: Leal, Pollyana C., et al.
Publicado: (2016)

Corrigendum: Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Neuropsychiatry in Demyelination Disease: Using Depression as a Prodrome for Early Diagnosis and Treatment of Multiple Sclerosis
por: Shail, Mrigank S
Publicado: (2017)

Progress in the development of gelling agents for improved culturability of microorganisms
por: Das, Nabajit, et al.
Publicado: (2015)

microRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's Disease
por: Xie, Yangmei, et al.
Publicado: (2016)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Differential impact of resilience on demoralization and depression in Parkinson disease
por: de Figueiredo, John M., et al.
Publicado: (2023)

A Tangled Web – Tau and Sporadic Parkinson's Disease
por: Wray, Selina, et al.
Publicado: (2010)

Potential application of lithium in Parkinson's and other neurodegenerative diseases
por: Lazzara, Carol A., et al.
Publicado: (2015)

Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
por: Błaszczyk, Janusz W.
Publicado: (2016)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Evaluation of Antidepressant Effect of Minocycline in Alcohol Abstinence-Induced Depression Model in Mice
por: Gajbhiye, Snehalata, et al.
Publicado: (2022)

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
por: Collins, Lucy M., et al.
Publicado: (2016)

Damaged Insula Network Contributes to Depression in Parkinson’s Disease
por: Huang, Peiyu, et al.
Publicado: (2020)

Stigma and Associated Correlates of Elderly Patients With Parkinson's Disease
por: Hou, Miaomiao, et al.
Publicado: (2021)

Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease
por: Pal, Gian D., et al.
Publicado: (2015)

From Perceived Stress to Demoralization in Parkinson Disease: A Path Analysis
por: de Figueiredo, John M., et al.
Publicado: (2022)

Test for Non-Synergistic Interactions in Phytomedicine, Just as You Do for Isolated Compounds
por: Patel, Areeba, et al.
Publicado: (2018)

Biopsable Neural Tissues: Toward New Biomarkers for Parkinson's Disease?
por: Lebouvier, Thibaud, et al.
Publicado: (2010)

An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression
por: Lian, Teng-Hong, et al.
Publicado: (2019)

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
por: Gallegos, Scarlet, et al.
Publicado: (2015)

Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies
por: Zhang, Jun-Fang, et al.
Publicado: (2021)

COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly
por: Janiri, Delfina, et al.
Publicado: (2020)

CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease
por: Pakarinen, Emmi, et al.
Publicado: (2023)

Effects of Kamikihito and Unkei-to on Sleep Behavior of Wild Type and Parkinson Model in Drosophila
por: Ito, Kumpei, et al.
Publicado: (2017)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

A Comparison of Treatment-Seeking Behavioral Addiction Patients with and without Parkinson’s Disease
por: Sauvaget, Anne, et al.
Publicado: (2017)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease
por: Wang, Ting, et al.
Publicado: (2015)

Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study
por: Qian, Yiwei, et al.
Publicado: (2021)

Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson’s Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task
por: Herzallah, Mohammad M., et al.
Publicado: (2017)

Cannabinoid Type 2 (CB(2)) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
por: Javed, Hayate, et al.
Publicado: (2016)

Drosophila larvae as a model to study physiological alcohol dependence
por: Robinson, Brooks G., et al.
Publicado: (2013)

Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown
por: Baschi, Roberta, et al.
Publicado: (2020)

Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease
por: Johnstone, Daniel M., et al.
Publicado: (2016)

Commentary: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
por: Olszewska, Diana A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9vg34qaeb8gck8g7lglqul61mt